Novo Nordisk’s Wegovy HD secures FDA greenlight amid patent expiries
Novo Nordisk has landed an approval from the US Food and Drug Administration (FDA) for a high dose version of…
20 Mar 2026
Novartis to acquire SNV4818 from Synnovation
Novartis has signed an agreement to acquire SNV4818, a pan-mutant selective Phosphoinositide 3-kinase alpha (PI3Kα) inhibitor, from Synnovation Therapeutics. Under the contract, Novartis will pay $2bn upfront and up to…
20 Mar 2026
Congruence secures $39.5m to advance small molecule correctors pipeline
Congruence Therapeutics has announced the completion of a $39.5m financing round to advance its portfolio of small molecule correctors into the clinic. The portfolio includes programmes targeting melanocortin 4 receptor…
20 Mar 2026
J&J wins FDA approval for Icotyde to enter psoriasis pill market
The US Food and Drug Administration (FDA) has approved Johnson & Johnson’s (J&J) Icotyde (icotrokinra) for the treatment of plaque psoriasis, marking the first US entry of an oral peptide…
19 Mar 2026
MHRA and NICE launch aligned pathway for faster medicine regulation
The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) will make their respective decisions on new drugs at the same time…
19 Mar 2026
Quintessence debuts first ‘living’ artificial cell for CGT bio-separation
Quintessence Biotech has launched a bio-separation tool to reduce the manufacturing bottleneck suffered by cell and gene therapies (CGTs), creating the first “living” artificial cell. DACS is a biomimetic lipid…
19 Mar 2026
Huntington’s gene therapy research has reached a turning point, expert says
Despite unanticipated regulatory hurdles following promising clinical results with a novel investigational treatment for Huntington’s Disease, the significance of the gene therapy’s impact remains strong, as per an expert. Earlier…